Inventor · disambiguated record
Frederique Bard
Also filed as: BARD FREDERIQUE · BARD FRÉDÉRIQUE
10 granted patents·13 pending applications·351 citations·filing 1995–2024
91Inventor score
Top patents by PatentIndex Score
23 records- 0198US6750324B1Humanized and chimeric N-terminal amyloid beta-antibodiesNEURALAB LTD·Filed 2000·Granted Jun 15, 2004·202 cites·12 claims
- 0296US11440953B2Anti-abeta antibodiesOTHAIR PROTHENA LTD·Filed 2022·Granted Sep 13, 2022·3 cites·19 claims
- 0396US11434283B2Anti-abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·3 cites·19 claims
- 0495US11434285B2Anti-Abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·2 cites·19 claims
- 0595US11434284B2Anti-Abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·2 cites·19 claims
- 0695US7575880B1Method of screening an antibody for activity in clearing an amyloid depositELAN PHARMA INT LTD·Filed 2000·Granted Aug 18, 2009·42 cites·4 claims
- 0790US7871615B2Humanized antibodies that recognize beta amyloid peptideJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2004·Granted Jan 18, 2011·46 cites·32 claims
- 0890US2025179161A1Anti-Abeta AntibodiesOTHAIR PROTHENA LTD·Filed 2024·Application pending·0 cites
- 0987US6664442B2Selecting compounds to reduce inflammation associated with Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Dec 16, 2003·29 cites·43 claims
- 1082US2023331828A1Anti-Abeta AntibodiesOTHAIR PROTHENA LTD·Filed 2022·Application pending·0 cites
- 1177US12435129B2Anti-Aβ antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Oct 7, 2025·0 cites·14 claims
- 1272US5811514AIntegrin blocking moleculeATHENA NEUROSCIENCES·Filed 1995·Granted Sep 22, 1998·22 cites·7 claims
- 1368US2004247590A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 1468US2005158304A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 1567US2004247591A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 1667US2004265301A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 1767US2006121038A9Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 1862US2005142132A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2005·Application pending·0 cites
- 1959US2008279873A1Active immunization to generate antibodies to soluble a-betaSEUBERT PETER A·Filed 2008·Application pending·0 cites
- 2059US2004213739A1Screening markers and methods for neurodegenerative disordersELAN PHARM INC·Filed 2003·Application pending·0 cites
- 2155US2023391859A1Anti-transthyretin antibodies and methods of use thereofNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 2254US2005059802A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 2353US2004213800A1Active immunization to generate antibodies to soluble A-betaFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frederique Bard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →